Rocket Lab's Split Personality: Record Contracts, a Pivotal Pivot, and a Stock Searching for Its Floor
Published on 07/31/2026 at 14:11 | Redaktion boerse-global.de
The gap between what Rocket Lab is achieving and what its share price is saying has rarely been wider. The company is signing contracts at a pace that would make most aerospace peers envious, yet its stock has spent the past month in a deep retreat. That disconnect — between a bulging order book and a chart that keeps sliding — is now the central question for anyone holding the shares.
The latest catalyst arrived this week in the form of the largest launch agreement in the company's history: a $266 million multi-launch deal with the US Space Force covering at least twelve suborbital missions for missile defense testing. The first launches from a new site at the Pacific Spaceport Complex in Alaska are targeted for late 2026. That followed news of three additional launch orders from Japanese satellite operator iQPS, marking the third multi-launch agreement with that customer within a year. The Space Force contract doesn't guarantee immediate revenue, but it opens the door to future missions and cements Rocket Lab's role in the "responsive space" niche — the ability to launch on short notice, a capability demonstrated during the Victus Haze mission when an Electron rocket lifted off with the shortest lead time in company history.
Investors responded with a 4.29% gain on Friday, lifting the stock to EUR 58.30. But that bounce looks modest against the broader damage: the shares remain down 33.75% over the past 30 days and sit 56.43% below the 52-week high of EUR 133.80 reached in late May. A day earlier, the stock had jumped 9.18% to EUR 55.90 following the contract announcements, though that still left it 58.22% off its peak. The whipsawing reflects an annualized 30-day volatility of roughly 97% — a market that is reacting to every headline with barely concealed nervousness.
The Strategic Makeover Behind the Noise
The extreme price swings obscure a more fundamental shift in what Rocket Lab is becoming. Late June brought the announcement of an approximately $8 billion acquisition of Iridium Communications, a move designed to push the company beyond its "we just launch rockets" identity. Iridium's established L-band spectrum and recurring service fees position Rocket Lab as a provider of complete space systems — from launch vehicles to satellite services. The market has responded by valuing the company at around EUR 35.11 billion, treating it as a credible challenger to established players.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The logic runs as follows: the dependable Electron business generates the cash flow to fund development of the larger Neutron rocket, while acquisitions like Iridium secure higher-margin service revenue. It's a strategy that requires execution on multiple fronts simultaneously — and that's precisely where the risk lies.
The Neutron Question
The bear case centers on a concrete technical setback. After a failed tank test on Neutron's first stage earlier this year, the rocket's maiden flight is now expected to slip to late 2026. Every additional delay keeps Rocket Lab tethered to the smaller, lower-margin Electron — and postpones entry into the more lucrative medium-to-heavy payload segment.
This risk is already priced into the stock. The 14-day RSI has moved from deeply oversold territory — reading 36.2 in one assessment, 39.4 in another — suggesting the shares are emerging from a near-term bottom. But a full trend reversal remains elusive, with the price still trading well below its 50-day moving average and roughly 13-17% under the 200-day average of around EUR 67.37.
What Comes Next
The immediate focus turns to launch cadence. The next iQPS mission is scheduled no earlier than August 2026, alongside ongoing Electron flights. But the pivotal date is August 10, 2026, when Rocket Lab reports second-quarter earnings. If management can demonstrate tangible progress on Neutron's technical issues or present a credible timeline for the Alaska launches, the stock could begin closing the gap toward that 200-day average. If quarterly losses come in worse than expected — or new Neutron delays surface — a retreat toward the 52-week low of EUR 32.60 becomes a real possibility.
Rocket Lab at a turning point? This analysis reveals what investors need to know now.
Analysts remain notably optimistic despite the turbulence, with an average price target of EUR 99.32 — implying roughly 70-78% upside from current levels. That optimism hinges on nearly flawless execution at two fronts: a successful Neutron debut by end-2026 and smooth integration of Iridium's assets.
Rocket Lab has maintained a spotless success record with core customers like iQPS. Whether that precision holds under the weight of much larger ambitions is the open question. The contracts keep coming, the strategy is clear, and the market cap reflects serious expectations. But until the stock finds its footing — and Neutron proves itself on the pad — the gap between Rocket Lab's achievements and its share price will keep testing investor patience.
Ad
Rocket Lab Stock: New Analysis - 31 July
Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
